A Canadian team used AI to make a cancer drug. Is this a game-changer?
The Big StoryPlay episode
Show notes
It's a process that can take up to a decade. And individual aspects of it can take up to a year or more. Or... it can take, like, a month.
The drug development process is time-consuming, intense and very, very expensive. So much so that only huge pharmaceutical companies can afford to keep swinging and missing. But a Canadian team using AI programs is aiming to change that—everything from the length of time to who can afford to do the work, and it just might revolutionize the entire process.
GUEST: Alán Aspuru-Guzik, professor of Chemistry and Computer Science at the University of Toronto; director of the Acceleration Consortium
We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:
Through email at hello@thebigstorypodcast.ca
Or @thebigstory.bsky.social on Bluesky
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
